Did your eGFR dip a few points in the first month after starting Jardiance (empagliflozin) or Farxiga, and how do you handle hydration?
My cardiologist added empagliflozin 10 mg to my Metformin for kidney and heart protection. At my 4-week metabolic panel, my eGFR went from 62 down to 56, which scared me at first. My doctor explained that SGLT2 inhibitors intentionally lower intraglomerular pressure inside the kidney filters—causing a small, reversible 3–6 point 'hemodynamic dip' right at the start before preserving kidney function long-term. Sure enough, by week 12 my eGFR stabilized at 60 and my urine albumin ratio improved. For anyone taking an SGLT2 inhibitor: what did your lab trend look like over the first 3–6 months, and what daily water or hygiene habits kept you side-effect free?
In the EMPA-KIDNEY and CREDENCE trials, an acute reversible eGFR dip of 3–5 mL/min/1.73m² during weeks 2–4 reflects reduced glomerular hyperfiltration via tubuloglomerular feedback. A drop <30% from baseline is expected and protective; patients should hold SGLT2 inhibitors during acute dehydrating illness or 3–4 days before surgery.